Neurodegenerative disease profoundly affects structures and pathways responsible for memory, cognition, and higher-order ...
Alzheimer disease (AD) is the most common cause of dementia and one of the leading causes of death in adults age 65 y or ...
The approval of disease-modifying antiamyloid therapies has expanded the clinical role of amyloid PET beyond diagnostic confirmation to include baseline characterization and longitudinal monitoring of ...
Amyloid PET has become a pivotal imaging biomarker for Alzheimer disease (AD), enabling in vivo detection and quantification ...
Journal of Nuclear Medicine Technology February 2026, jnmt.125.271265; DOI: https://doi.org/10.2967/jnmt.125.271265 ...
This special contribution provides insight into the role that standard operating procedures (SOPs) play in an imaging department and their value in building a high-quality research site. If you have ...
The year 1969 was an auspicious one for the profession that we now call nuclear medicine technology. The Technical Education Research Center of the U.S. Department of Health, Education, and Welfare ...
The growing demand for amyloid and tau PET imaging, driven by new dementia therapies and biomarker-based diagnosis, has ...
In 1966, Griffith et al. used “a standard breakfast of ordinary food” labeled with chromium-51 to report the first use of gastric emptying scintigraphy (GES). As the procedure was refined over the ...
The challenges of hybridizing PET and MRI as a simultaneous modality have been largely overcome in recent times. PET hybridized with MRI has seen the emergence of PET/MRI systems in the clinical ...
In recent years, there has been an influx of new tracers into the field of nuclear medicine and molecular imaging. Most of those that have been Food and Drug Administration–approved for clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results